Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
Brightmeds Review
An in-depth look at Brightmeds — compounded semaglutide and tirzepatide with no separate consultation fee. What sets it apart is a real clinical eligibility gate: it will decline you if your BMI does not qualify, which is rarer in this category than it should be.
Brightmeds
Clinical Eligibility GateBrightmeds is a telehealth weight-management platform offering compounded semaglutide and tirzepatide, oral semaglutide, and — unusually — non-GLP-1 options including bupropion, naltrexone and topiramate. Pricing starts around $189/month for compounded semaglutide, with no separate consultation fee and no hidden charges. Insurance is not accepted.
The reason it earns a higher rating than several cheaper rivals is that it applies an actual clinical threshold. Brightmeds states that treatment requires a BMI of 30 or above, or 27 or above with a weight-related comorbidity such as pre-diabetes, hypertension or sleep apnoea. That mirrors the criteria used for the FDA-approved products, and it means the platform will turn people away. In a category where plenty of operators approve essentially anyone who pays, being willing to decline is a meaningful quality signal.
Offering non-GLP-1 medication matters for the same reason. Bupropion, naltrexone and topiramate are older, cheaper, FDA-approved options that suit some patients better — a platform that stocks them is not simply funnelling every visitor toward the most expensive product.
We found no FDA warning letter against Brightmeds, which distinguishes it from roughly a dozen providers on this site. What keeps the rating at 4.0 rather than higher: reported pricing varies widely between sources, from around $75 to $189 depending on plan and dose, so confirm your own quote; compounded medication is not FDA-approved; and there is no insurance pathway at all.
Affiliate disclosure: GLP1Drugs.org earns a commission if you sign up through the links on this page. It does not affect our rating. Pricing checked 29 July 2026; reported figures vary between sources, so confirm your own quote.
Visit BrightmedsOur Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
$189
Semaglutide From / Month
BMI 30+
Eligibility Threshold
$0
Consultation Fee
Yes
Non-GLP-1 Options
Eligibility & Options
What Brightmeds offers and who qualifies. Checked 29 July 2026.
| Option | Type | FDA-Approved | Eligibility | Notes |
|---|---|---|---|---|
| Compounded semaglutide | Injectable | No | BMI 30+, or 27+ with comorbidity | From ~$189/mo |
| Compounded tirzepatide | Injectable | No | BMI 30+, or 27+ with comorbidity | Higher by dose |
| Oral semaglutide | Oral | No | Same threshold | No published bioavailability data |
| Bupropion / naltrexone | Oral | Yes | Clinician judgement | Older, cheaper, well characterised |
| Topiramate | Oral | Yes | Clinician judgement | Off-label for weight; real side effects |
That last group is worth pausing on. Bupropion, naltrexone and topiramate are FDA-approved drugs with decades of safety data, and for some patients they are a better or cheaper fit than a compounded GLP-1. Topiramate in particular carries genuine risks — including harm in pregnancy — so it needs a proper conversation rather than a checkout choice. But a platform that offers them at all is one that is not simply routing everyone to the highest-margin product.
What's Included
Compounded GLP-1 Medication
Compounded semaglutide and tirzepatide from licensed US pharmacies — not FDA pre-market approved
Non-GLP-1 Alternatives
Bupropion, naltrexone and topiramate, which are FDA-approved medications used in weight management
No Consultation Fee
The online consultation is bundled rather than billed separately
Clinical Eligibility Screening
A stated BMI threshold of 30+, or 27+ with a weight-related comorbidity
Home Delivery
Medication shipped to the patient after clinician approval
Cash-Pay Only
No insurance is accepted, so all costs are out of pocket
Pros & Cons
Pros
- ✓Applies a real clinical eligibility threshold — BMI 30+, or 27+ with a comorbidity — and will decline people who do not meet it
- ✓Offers FDA-approved non-GLP-1 alternatives rather than routing everyone to compounded medication
- ✓No separate consultation fee and no hidden charges
- ✓Competitive entry pricing from around $189/month
- ✓No FDA warning letter found against it
- ✓Both injectable and oral formats available
Cons
- ✕Reported pricing varies substantially between sources — confirm your own quote before paying
- ✕No insurance accepted, so the full cost is out of pocket
- ✕Compounded medications are not FDA-approved or evaluated for safety, effectiveness or quality
- ✕The oral semaglutide option has no published bioavailability data in compounded form
- ✕Topiramate is used off-label for weight loss and carries meaningful risks, including in pregnancy
- ✕Less independent review history than the largest platforms
Our Verdict
4.0 / 5 — one of the few cash-pay platforms with a genuine eligibility gate and FDA-approved alternatives on the menu, held back by inconsistent published pricing and no insurance pathway.
Brightmeds does two things that most of this category does not: it applies a real BMI threshold and turns people away, and it stocks older FDA-approved weight-loss medications alongside the compounded GLP-1s. Both suggest a platform making clinical decisions rather than purely commercial ones, and neither costs it anything in our rating — they earn it. The reservations are practical rather than ethical: reported prices vary too widely between sources to quote confidently, there is no insurance route, and compounded medication carries the usual caveats. Get your quote in writing at your target dose and it is a reasonable choice.
Visit BrightmedsFrequently Asked Questions
How much does Brightmeds cost?
Reported pricing starts around $189/month for compounded semaglutide, with tirzepatide higher depending on dose, and some sources citing entry promotions as low as $75. That spread is wide enough that we would not rely on any single figure — confirm your own quote, at your target dose, before paying. There is no separate consultation fee and no insurance is accepted, so what you are quoted is what you pay.
Do I qualify for treatment?
Brightmeds states that a prescription requires a BMI of 30 or above, or 27 or above with a weight-related condition such as pre-diabetes, hypertension or sleep apnoea. Those are broadly the criteria used for the FDA-approved weight-management products. If you do not meet them, the platform says it will not prescribe — which is the correct answer, even though it is not the one every shopper wants.
Why is a BMI requirement a good thing?
Because it means someone is actually assessing whether treatment is appropriate. GLP-1 medications are not risk-free, and a platform willing to prescribe to anyone who pays is prioritising conversion over care. A stated threshold that results in some people being declined is one of the more reliable quality signals available to you when comparing cash-pay telehealth providers.
What are the non-GLP-1 options?
Bupropion, naltrexone and topiramate — all FDA-approved medications, used alone or in combination for weight management. They are older, generally cheaper, and extremely well characterised compared with compounded GLP-1s. They are not automatically better: topiramate in particular carries real risks including harm in pregnancy and cognitive side effects, and naltrexone interacts with opioids. But having them available means your clinician has options beyond the most expensive product.
Is Brightmeds legitimate?
We found no FDA warning letter against Brightmeds, which is a meaningful distinction in a category where the agency has written to dozens of telehealth firms over compounded GLP-1 marketing. It uses licensed professionals, applies a clinical eligibility screen, and does not charge a hidden consultation fee. Its independent review footprint is thinner than the largest platforms, so there is less third-party evidence to check than for an established brand.
What are the side effects?
For GLP-1s: commonly nausea, vomiting, diarrhoea and constipation, worst during dose escalation, with more serious risks including pancreatitis and gallbladder disease. They are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2 and in pregnancy. The non-GLP-1 options have their own profiles — bupropion can lower seizure threshold, naltrexone blocks opioid pain relief, and topiramate can cause cognitive slowing and is harmful in pregnancy. Discuss your history with the prescribing clinician.
Ready to Get Started?
Check whether you meet the BMI threshold before paying, and ask what your price is at your target dose rather than the starting one.
Visit BrightmedsCompare Other GLP-1 Providers
See how other telehealth providers stack up.
Form Health
Comprehensive ProgramMultidisciplinary obesity medicine program with physicians, dietitians, and behavioral coaching
Read Review →Henry Meds
Top RatedWell-established telehealth platform with fast physician reviews and competitive pricing
Read Review →Boston Medical Group
Top RatedEstablished telehealth provider with physician oversight and transparent pricing
Read Review →BeyondMD
Top RatedBoard-certified physician-led care with comprehensive medical oversight
Read Review →LifeMD
Top RatedPublicly traded telehealth company with comprehensive health platform and competitive pricing
Read Review →GoodRx Care
Trusted BrandTelehealth platform from GoodRx with transparent pricing and established trust
Read Review →Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness or quality. GLP-1 medications commonly cause nausea, vomiting, diarrhoea and constipation and carry risks including pancreatitis and gallbladder disease; they are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2 and in pregnancy. Bupropion, naltrexone and topiramate carry their own significant risks, including seizure risk, opioid interaction, and foetal harm respectively, and topiramate is used off-label for weight management. Prescribing is subject to clinician approval and eligibility criteria, and is not guaranteed. Always consult a qualified healthcare provider.
Pricing Note: Prices checked 29 July 2026. Reported figures vary between sources from roughly $75 to $189 depending on plan and dose; confirm your own quote directly before paying. No insurance is accepted.
Affiliate Disclosure: This site may receive compensation from affiliate partners, including Brightmeds. This does not influence our editorial content or review ratings.